Yongxue Yao
Overview
Explore the profile of Yongxue Yao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
786
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen J, Qu M, Zhang J, Yao Y, Pei X, Wu W, et al.
Anal Methods
. 2024 Sep;
16(42):7139-7147.
PMID: 39295462
This work presents the design and synthesis of a new fluorescent probe IF-Br-F for the specific detection of fluoride ions. The IF-Br-F probe has excellent fluorescence properties, and the mechanism...
2.
Chen J, Yao Y, Pei X, Qu M, Zhang J, Hu W, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2024 Aug;
324:125009.
PMID: 39178691
Fluoride ions (F) are one of the essential trace elements for the human body and are widely existed in nature. In this study, we present a novel fluorescent probe (YF-SZ-F)...
3.
Lam T, Yao Y, Trockman J
JAMA Dermatol
. 2014 Jul;
150(9):1019-20.
PMID: 25007065
No abstract available.
4.
Yao Y, Robertson C, Lee K, Somani A
Dermatol Surg
. 2013 Aug;
39(11):1699-702.
PMID: 23898940
No abstract available.
5.
Yao Y, Mark L
Cutis
. 2013 Feb;
90(6):307-9, 316.
PMID: 23409481
Woringer-Kolopp disease, also known as localized pagetoid reticulosis, is a rare cutaneous lymphoproliferative disorder classified as a solitary variant of mycosis fungoides (MF). Despite the indolent and benign nature of...
6.
Yao Y, Harrison K, Al-Hassani M, Murphy R, Rezania S, Konger R, et al.
J Biol Chem
. 2012 Feb;
287(12):9311-21.
PMID: 22303003
To date, oxidized glycerophosphocholines (Ox-GPCs) with platelet-activating factor (PAF) activity produced non-enzymatically have not been definitively demonstrated to mediate any known disease processes. Here we provide evidence that these Ox-GPCs...
7.
Sahu R, Kozman A, Yao Y, DaSilva S, Rezania S, Martel K, et al.
Carcinogenesis
. 2012 Jan;
33(3):694-701.
PMID: 22223848
Although platelet-activating factor (PAF) is a well-known acute inflammatory mediator, little is known regarding the role of PAF in chronic inflammation. Phorbol esters are known to stimulate PAF production. Moreover,...
8.
Sahu R, Yao Y, Konger R, Travers J
Photochem Photobiol
. 2012 Jan;
88(2):490-3.
PMID: 22211638
The lipid mediator Platelet-activating factor (PAF) and oxidized glycerophosphocholine PAF agonists produced by UVB have been demonstrated to play a pivotal role in UVB-mediated systemic immunosuppression. Importantly, employing the ability...
9.
Travers J, Kozman A, Yao Y, Ming W, Yao W, Turner M, et al.
Pediatr Dermatol
. 2011 Dec;
29(3):289-96.
PMID: 22150395
Patients with atopic dermatitis (AD) are predisposed to infection with Staphylococcus aureus, which worsens their skin disease; it has been postulated that the lack of antimicrobial peptides due to aberrant...
10.
Cheng L, Zhang S, Alexander R, Yao Y, MacLennan G, Pan C, et al.
Future Oncol
. 2011 Apr;
7(4):519-41.
PMID: 21463141
Two classes of anti-EGF receptor (EGFR) agents, monoclonal anti-EGFR antibodies and small-molecule EGFR tyrosine kinase inhibitors, have been used for the treatment of non-small-cell lung cancer (NSCLC). However, only a...